世界の抗血栓剤市場予測2023-2029:抗凝固薬、抗血小板薬

【英語タイトル】Antithrombotic Agent Market, Global Outlook and Forecast 2023-2029

Market Monitor Globalが出版した調査資料(MMG23FB2160)・商品コード:MMG23FB2160
・発行会社(調査会社):Market Monitor Global
・発行日:2023年2月
・ページ数:68
・レポート言語:英語
・レポート形式:PDF
・納品方法:Eメール(受注後2-3営業日)
・調査対象地域:グローバル、北米、アメリカ、ヨーロッパ、アジア、日本、中国、東南アジア、インド、南米、中東・アフリカなど
・産業分野:医療
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD3,250 ⇒換算¥494,000見積依頼/購入/質問フォーム
Multi User(20名様閲覧用)USD4,225 ⇒換算¥642,200見積依頼/購入/質問フォーム
Enterprise User(閲覧人数制限なし)USD4,875 ⇒換算¥741,000見積依頼/購入/質問フォーム
販売価格オプションの説明
※お支払金額:換算金額(日本円)+消費税
※納期:即日〜2営業日(3日以上かかる場合は別途表記又はご連絡)
※お支払方法:納品日+5日以内に請求書を発行・送付(請求書発行日より2ヶ月以内に銀行振込、振込先:三菱UFJ銀行/H&Iグローバルリサーチ株式会社、支払期限と方法は調整可能)
❖ レポートの概要 ❖

当調査レポートは次の情報を含め、世界の抗血栓剤市場規模と予測を収録しています。・世界の抗血栓剤市場:売上、2018年-2023年、2024年-2029年
・世界の抗血栓剤市場:販売量、2018年-2023年、2024年-2029年
・世界のトップ5企業、2022年

世界の抗血栓剤市場は2022年に000Mドルと評価され、予測期間中に000%のCAGRで2029年までに000Mドルに達すると予測されています。米国市場は2022年に000Mドルと推定されており、中国は2029年までに000Mドルに達すると予測されています。「抗凝固薬」セグメントは今後6年間、000%のCAGRで2029年までに000Mドルに成長すると予測されています。

抗血栓剤のグローバル主要企業は、Pfizer、Bayer、Johnson & Johnson、Boehringer Ingelheim Pharmaceuticals、Daiichi Sankyo、Sanofi、GlaxoSmithKline、Bristol Myers Squibb Pharma、Pliva、Sandoz、Pharmaciaなどです。2022年にトップ5企業がグローバル売上シェアの約000%を占めています。

MARKET MONITOR GLOBAL(MMG)は、抗血栓剤のメーカー、サプライヤー、流通業者、および業界の専門家を調査しました。これには、販売量、売上、需要、価格変動、製品タイプ、最近の動向と計画、産業トレンド、成長要因、課題、阻害要因、潜在的なリスクなどが含まれます。

【セグメント別市場分析】

世界の抗血栓剤市場:タイプ別、2018年-2023年、2024年-2029年
世界の抗血栓剤市場:タイプ別市場シェア、2022年
・抗凝固薬、抗血小板薬

世界の抗血栓剤市場:用途別、2018年-2023年、2024年-2029年
世界の抗血栓剤市場:用途別市場シェア、2022年
・病院、ドラッグストア、その他

世界の抗血栓剤市場:地域・国別、2018年-2023年、2024年-2029年
世界の抗血栓剤市場:地域別市場シェア、2022年
・北米:アメリカ、カナダ、メキシコ
・ヨーロッパ:ドイツ、フランス、イギリス、イタリア、ロシア
・アジア:中国、日本、韓国、東南アジア、インド
・南米:ブラジル、アルゼンチン
・中東・アフリカ:トルコ、イスラエル、サウジアラビア、UAE

【競合分析】

また、当レポートは主要な市場参加者の分析を提供します。
・主要企業における抗血栓剤のグローバル売上、2018年-2023年
・主要企業における抗血栓剤のグローバル売上シェア、2022年
・主要企業における抗血栓剤のグローバル販売量、2018年-2023年
・主要企業における抗血栓剤のグローバル販売量シェア、2022年

さらに、当レポートは主要企業のプロファイルを提示します。
Pfizer、Bayer、Johnson & Johnson、Boehringer Ingelheim Pharmaceuticals、Daiichi Sankyo、Sanofi、GlaxoSmithKline、Bristol Myers Squibb Pharma、Pliva、Sandoz、Pharmacia

*************************************************************

・調査・分析レポートの概要
抗血栓剤市場の定義
市場セグメント
世界の抗血栓剤市場概要
当レポートの特徴・ベネフィット
調査手法と情報源

・世界の抗血栓剤市場規模
世界の抗血栓剤市場規模:2022年 VS 2029年
世界の抗血栓剤市場規模と予測 2018年-2029年

・競争状況
グローバルトップ企業
売上ベースでのグローバルトップ企業
企業別グローバルでの抗血栓剤の売上
グローバルトップ3およびトップ5企業、2022年売上ベース
グローバル企業の抗血栓剤製品タイプ
グローバルにおけるティア1、ティア2、ティア3企業

・タイプ別市場分析
タイプ区分:抗凝固薬、抗血小板薬
抗血栓剤のタイプ別グローバル売上・予測

・用途別市場分析
用途区分:病院、ドラッグストア、その他
抗血栓剤の用途別グローバル売上・予測

・地域別市場分析
地域別抗血栓剤市場規模 2022年と2029年
地域別抗血栓剤売上・予測
北米市場:アメリカ、カナダ、メキシコ
ヨーロッパ市場:ドイツ、フランス、イギリス、イタリア、ロシア
アジア市場:中国、日本、韓国、東南アジア、インド
南米市場:ブラジル、アルゼンチン
中東・アフリカ市場:トルコ、イスラエル、サウジアラビア、UAE

・主要企業のプロファイル(企業概要、事業概要、主要製品、売上、ニュースなど)
Pfizer、Bayer、Johnson & Johnson、Boehringer Ingelheim Pharmaceuticals、Daiichi Sankyo、Sanofi、GlaxoSmithKline、Bristol Myers Squibb Pharma、Pliva、Sandoz、Pharmacia

グローバル市場調査レポート販売サイトのwww.marketreport.jpです。

❖ レポートの目次 ❖

1 Introduction to Research & Analysis Reports
1.1 Antithrombotic Agent Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Antithrombotic Agent Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Antithrombotic Agent Overall Market Size
2.1 Global Antithrombotic Agent Market Size: 2022 VS 2029
2.2 Global Antithrombotic Agent Market Size, Prospects & Forecasts: 2018-2029
2.3 Key Market Trends, Opportunity, Drivers and Restraints
2.3.1 Market Opportunities & Trends
2.3.2 Market Drivers
2.3.3 Market Restraints
3 Company Landscape
3.1 Top Antithrombotic Agent Players in Global Market
3.2 Top Global Antithrombotic Agent Companies Ranked by Revenue
3.3 Global Antithrombotic Agent Revenue by Companies
3.4 Top 3 and Top 5 Antithrombotic Agent Companies in Global Market, by Revenue in 2022
3.5 Global Companies Antithrombotic Agent Product Type
3.6 Tier 1, Tier 2 and Tier 3 Antithrombotic Agent Players in Global Market
3.6.1 List of Global Tier 1 Antithrombotic Agent Companies
3.6.2 List of Global Tier 2 and Tier 3 Antithrombotic Agent Companies
4 Market Sights by Product
4.1 Overview
4.1.1 By Type – Global Antithrombotic Agent Market Size Markets, 2022 & 2029
4.1.2 Anticoagulant
4.1.3 Antiplatelet Drug
4.2 By Type – Global Antithrombotic Agent Revenue & Forecasts
4.2.1 By Type – Global Antithrombotic Agent Revenue, 2018-2023
4.2.2 By Type – Global Antithrombotic Agent Revenue, 2024-2029
4.2.3 By Type – Global Antithrombotic Agent Revenue Market Share, 2018-2029
5 Sights by Application
5.1 Overview
5.1.1 By Application – Global Antithrombotic Agent Market Size, 2022 & 2029
5.1.2 Hospital
5.1.3 Drugs Stores
5.1.4 Others
5.2 By Application – Global Antithrombotic Agent Revenue & Forecasts
5.2.1 By Application – Global Antithrombotic Agent Revenue, 2018-2023
5.2.2 By Application – Global Antithrombotic Agent Revenue, 2024-2029
5.2.3 By Application – Global Antithrombotic Agent Revenue Market Share, 2018-2029
6 Sights by Region
6.1 By Region – Global Antithrombotic Agent Market Size, 2022 & 2029
6.2 By Region – Global Antithrombotic Agent Revenue & Forecasts
6.2.1 By Region – Global Antithrombotic Agent Revenue, 2018-2023
6.2.2 By Region – Global Antithrombotic Agent Revenue, 2024-2029
6.2.3 By Region – Global Antithrombotic Agent Revenue Market Share, 2018-2029
6.3 North America
6.3.1 By Country – North America Antithrombotic Agent Revenue, 2018-2029
6.3.2 US Antithrombotic Agent Market Size, 2018-2029
6.3.3 Canada Antithrombotic Agent Market Size, 2018-2029
6.3.4 Mexico Antithrombotic Agent Market Size, 2018-2029
6.4 Europe
6.4.1 By Country – Europe Antithrombotic Agent Revenue, 2018-2029
6.4.2 Germany Antithrombotic Agent Market Size, 2018-2029
6.4.3 France Antithrombotic Agent Market Size, 2018-2029
6.4.4 U.K. Antithrombotic Agent Market Size, 2018-2029
6.4.5 Italy Antithrombotic Agent Market Size, 2018-2029
6.4.6 Russia Antithrombotic Agent Market Size, 2018-2029
6.4.7 Nordic Countries Antithrombotic Agent Market Size, 2018-2029
6.4.8 Benelux Antithrombotic Agent Market Size, 2018-2029
6.5 Asia
6.5.1 By Region – Asia Antithrombotic Agent Revenue, 2018-2029
6.5.2 China Antithrombotic Agent Market Size, 2018-2029
6.5.3 Japan Antithrombotic Agent Market Size, 2018-2029
6.5.4 South Korea Antithrombotic Agent Market Size, 2018-2029
6.5.5 Southeast Asia Antithrombotic Agent Market Size, 2018-2029
6.5.6 India Antithrombotic Agent Market Size, 2018-2029
6.6 South America
6.6.1 By Country – South America Antithrombotic Agent Revenue, 2018-2029
6.6.2 Brazil Antithrombotic Agent Market Size, 2018-2029
6.6.3 Argentina Antithrombotic Agent Market Size, 2018-2029
6.7 Middle East & Africa
6.7.1 By Country – Middle East & Africa Antithrombotic Agent Revenue, 2018-2029
6.7.2 Turkey Antithrombotic Agent Market Size, 2018-2029
6.7.3 Israel Antithrombotic Agent Market Size, 2018-2029
6.7.4 Saudi Arabia Antithrombotic Agent Market Size, 2018-2029
6.7.5 UAE Antithrombotic Agent Market Size, 2018-2029
7 Antithrombotic Agent Companies Profiles
7.1 Pfizer
7.1.1 Pfizer Company Summary
7.1.2 Pfizer Business Overview
7.1.3 Pfizer Antithrombotic Agent Major Product Offerings
7.1.4 Pfizer Antithrombotic Agent Revenue in Global Market (2018-2023)
7.1.5 Pfizer Key News & Latest Developments
7.2 Bayer
7.2.1 Bayer Company Summary
7.2.2 Bayer Business Overview
7.2.3 Bayer Antithrombotic Agent Major Product Offerings
7.2.4 Bayer Antithrombotic Agent Revenue in Global Market (2018-2023)
7.2.5 Bayer Key News & Latest Developments
7.3 Johnson & Johnson
7.3.1 Johnson & Johnson Company Summary
7.3.2 Johnson & Johnson Business Overview
7.3.3 Johnson & Johnson Antithrombotic Agent Major Product Offerings
7.3.4 Johnson & Johnson Antithrombotic Agent Revenue in Global Market (2018-2023)
7.3.5 Johnson & Johnson Key News & Latest Developments
7.4 Boehringer Ingelheim Pharmaceuticals
7.4.1 Boehringer Ingelheim Pharmaceuticals Company Summary
7.4.2 Boehringer Ingelheim Pharmaceuticals Business Overview
7.4.3 Boehringer Ingelheim Pharmaceuticals Antithrombotic Agent Major Product Offerings
7.4.4 Boehringer Ingelheim Pharmaceuticals Antithrombotic Agent Revenue in Global Market (2018-2023)
7.4.5 Boehringer Ingelheim Pharmaceuticals Key News & Latest Developments
7.5 Daiichi Sankyo
7.5.1 Daiichi Sankyo Company Summary
7.5.2 Daiichi Sankyo Business Overview
7.5.3 Daiichi Sankyo Antithrombotic Agent Major Product Offerings
7.5.4 Daiichi Sankyo Antithrombotic Agent Revenue in Global Market (2018-2023)
7.5.5 Daiichi Sankyo Key News & Latest Developments
7.6 Sanofi
7.6.1 Sanofi Company Summary
7.6.2 Sanofi Business Overview
7.6.3 Sanofi Antithrombotic Agent Major Product Offerings
7.6.4 Sanofi Antithrombotic Agent Revenue in Global Market (2018-2023)
7.6.5 Sanofi Key News & Latest Developments
7.7 GlaxoSmithKline
7.7.1 GlaxoSmithKline Company Summary
7.7.2 GlaxoSmithKline Business Overview
7.7.3 GlaxoSmithKline Antithrombotic Agent Major Product Offerings
7.7.4 GlaxoSmithKline Antithrombotic Agent Revenue in Global Market (2018-2023)
7.7.5 GlaxoSmithKline Key News & Latest Developments
7.8 Bristol Myers Squibb Pharma
7.8.1 Bristol Myers Squibb Pharma Company Summary
7.8.2 Bristol Myers Squibb Pharma Business Overview
7.8.3 Bristol Myers Squibb Pharma Antithrombotic Agent Major Product Offerings
7.8.4 Bristol Myers Squibb Pharma Antithrombotic Agent Revenue in Global Market (2018-2023)
7.8.5 Bristol Myers Squibb Pharma Key News & Latest Developments
7.9 Pliva
7.9.1 Pliva Company Summary
7.9.2 Pliva Business Overview
7.9.3 Pliva Antithrombotic Agent Major Product Offerings
7.9.4 Pliva Antithrombotic Agent Revenue in Global Market (2018-2023)
7.9.5 Pliva Key News & Latest Developments
7.10 Sandoz
7.10.1 Sandoz Company Summary
7.10.2 Sandoz Business Overview
7.10.3 Sandoz Antithrombotic Agent Major Product Offerings
7.10.4 Sandoz Antithrombotic Agent Revenue in Global Market (2018-2023)
7.10.5 Sandoz Key News & Latest Developments
7.11 Pharmacia
7.11.1 Pharmacia Company Summary
7.11.2 Pharmacia Business Overview
7.11.3 Pharmacia Antithrombotic Agent Major Product Offerings
7.11.4 Pharmacia Antithrombotic Agent Revenue in Global Market (2018-2023)
7.11.5 Pharmacia Key News & Latest Developments
8 Conclusion
9 Appendix
9.1 Note
9.2 Examples of Clients
9.3 Disclaimer

List of Tables
Table 1. Antithrombotic Agent Market Opportunities & Trends in Global Market
Table 2. Antithrombotic Agent Market Drivers in Global Market
Table 3. Antithrombotic Agent Market Restraints in Global Market
Table 4. Key Players of Antithrombotic Agent in Global Market
Table 5. Top Antithrombotic Agent Players in Global Market, Ranking by Revenue (2022)
Table 6. Global Antithrombotic Agent Revenue by Companies, (US$, Mn), 2018-2023
Table 7. Global Antithrombotic Agent Revenue Share by Companies, 2018-2023
Table 8. Global Companies Antithrombotic Agent Product Type
Table 9. List of Global Tier 1 Antithrombotic Agent Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Antithrombotic Agent Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 11. By Type – Global Antithrombotic Agent Revenue, (US$, Mn), 2022 & 2029
Table 12. By Type - Antithrombotic Agent Revenue in Global (US$, Mn), 2018-2023
Table 13. By Type - Antithrombotic Agent Revenue in Global (US$, Mn), 2024-2029
Table 14. By Application – Global Antithrombotic Agent Revenue, (US$, Mn), 2022 & 2029
Table 15. By Application - Antithrombotic Agent Revenue in Global (US$, Mn), 2018-2023
Table 16. By Application - Antithrombotic Agent Revenue in Global (US$, Mn), 2024-2029
Table 17. By Region – Global Antithrombotic Agent Revenue, (US$, Mn), 2022 & 2029
Table 18. By Region - Global Antithrombotic Agent Revenue (US$, Mn), 2018-2023
Table 19. By Region - Global Antithrombotic Agent Revenue (US$, Mn), 2024-2029
Table 20. By Country - North America Antithrombotic Agent Revenue, (US$, Mn), 2018-2023
Table 21. By Country - North America Antithrombotic Agent Revenue, (US$, Mn), 2024-2029
Table 22. By Country - Europe Antithrombotic Agent Revenue, (US$, Mn), 2018-2023
Table 23. By Country - Europe Antithrombotic Agent Revenue, (US$, Mn), 2024-2029
Table 24. By Region - Asia Antithrombotic Agent Revenue, (US$, Mn), 2018-2023
Table 25. By Region - Asia Antithrombotic Agent Revenue, (US$, Mn), 2024-2029
Table 26. By Country - South America Antithrombotic Agent Revenue, (US$, Mn), 2018-2023
Table 27. By Country - South America Antithrombotic Agent Revenue, (US$, Mn), 2024-2029
Table 28. By Country - Middle East & Africa Antithrombotic Agent Revenue, (US$, Mn), 2018-2023
Table 29. By Country - Middle East & Africa Antithrombotic Agent Revenue, (US$, Mn), 2024-2029
Table 30. Pfizer Company Summary
Table 31. Pfizer Antithrombotic Agent Product Offerings
Table 32. Pfizer Antithrombotic Agent Revenue (US$, Mn) & (2018-2023)
Table 33. Pfizer Key News & Latest Developments
Table 34. Bayer Company Summary
Table 35. Bayer Antithrombotic Agent Product Offerings
Table 36. Bayer Antithrombotic Agent Revenue (US$, Mn) & (2018-2023)
Table 37. Bayer Key News & Latest Developments
Table 38. Johnson & Johnson Company Summary
Table 39. Johnson & Johnson Antithrombotic Agent Product Offerings
Table 40. Johnson & Johnson Antithrombotic Agent Revenue (US$, Mn) & (2018-2023)
Table 41. Johnson & Johnson Key News & Latest Developments
Table 42. Boehringer Ingelheim Pharmaceuticals Company Summary
Table 43. Boehringer Ingelheim Pharmaceuticals Antithrombotic Agent Product Offerings
Table 44. Boehringer Ingelheim Pharmaceuticals Antithrombotic Agent Revenue (US$, Mn) & (2018-2023)
Table 45. Boehringer Ingelheim Pharmaceuticals Key News & Latest Developments
Table 46. Daiichi Sankyo Company Summary
Table 47. Daiichi Sankyo Antithrombotic Agent Product Offerings
Table 48. Daiichi Sankyo Antithrombotic Agent Revenue (US$, Mn) & (2018-2023)
Table 49. Daiichi Sankyo Key News & Latest Developments
Table 50. Sanofi Company Summary
Table 51. Sanofi Antithrombotic Agent Product Offerings
Table 52. Sanofi Antithrombotic Agent Revenue (US$, Mn) & (2018-2023)
Table 53. Sanofi Key News & Latest Developments
Table 54. GlaxoSmithKline Company Summary
Table 55. GlaxoSmithKline Antithrombotic Agent Product Offerings
Table 56. GlaxoSmithKline Antithrombotic Agent Revenue (US$, Mn) & (2018-2023)
Table 57. GlaxoSmithKline Key News & Latest Developments
Table 58. Bristol Myers Squibb Pharma Company Summary
Table 59. Bristol Myers Squibb Pharma Antithrombotic Agent Product Offerings
Table 60. Bristol Myers Squibb Pharma Antithrombotic Agent Revenue (US$, Mn) & (2018-2023)
Table 61. Bristol Myers Squibb Pharma Key News & Latest Developments
Table 62. Pliva Company Summary
Table 63. Pliva Antithrombotic Agent Product Offerings
Table 64. Pliva Antithrombotic Agent Revenue (US$, Mn) & (2018-2023)
Table 65. Pliva Key News & Latest Developments
Table 66. Sandoz Company Summary
Table 67. Sandoz Antithrombotic Agent Product Offerings
Table 68. Sandoz Antithrombotic Agent Revenue (US$, Mn) & (2018-2023)
Table 69. Sandoz Key News & Latest Developments
Table 70. Pharmacia Company Summary
Table 71. Pharmacia Antithrombotic Agent Product Offerings
Table 72. Pharmacia Antithrombotic Agent Revenue (US$, Mn) & (2018-2023)
Table 73. Pharmacia Key News & Latest Developments
List of Figures
Figure 1. Antithrombotic Agent Segment by Type in 2022
Figure 2. Antithrombotic Agent Segment by Application in 2022
Figure 3. Global Antithrombotic Agent Market Overview: 2022
Figure 4. Key Caveats
Figure 5. Global Antithrombotic Agent Market Size: 2022 VS 2029 (US$, Mn)
Figure 6. Global Antithrombotic Agent Revenue, 2018-2029 (US$, Mn)
Figure 7. The Top 3 and 5 Players Market Share by Antithrombotic Agent Revenue in 2022
Figure 8. By Type - Global Antithrombotic Agent Revenue Market Share, 2018-2029
Figure 9. By Application - Global Antithrombotic Agent Revenue Market Share, 2018-2029
Figure 10. By Type - Global Antithrombotic Agent Revenue, (US$, Mn), 2022 & 2029
Figure 11. By Type - Global Antithrombotic Agent Revenue Market Share, 2018-2029
Figure 12. By Application - Global Antithrombotic Agent Revenue, (US$, Mn), 2022 & 2029
Figure 13. By Application - Global Antithrombotic Agent Revenue Market Share, 2018-2029
Figure 14. By Region - Global Antithrombotic Agent Revenue Market Share, 2018-2029
Figure 15. By Country - North America Antithrombotic Agent Revenue Market Share, 2018-2029
Figure 16. US Antithrombotic Agent Revenue, (US$, Mn), 2018-2029
Figure 17. Canada Antithrombotic Agent Revenue, (US$, Mn), 2018-2029
Figure 18. Mexico Antithrombotic Agent Revenue, (US$, Mn), 2018-2029
Figure 19. By Country - Europe Antithrombotic Agent Revenue Market Share, 2018-2029
Figure 20. Germany Antithrombotic Agent Revenue, (US$, Mn), 2018-2029
Figure 21. France Antithrombotic Agent Revenue, (US$, Mn), 2018-2029
Figure 22. U.K. Antithrombotic Agent Revenue, (US$, Mn), 2018-2029
Figure 23. Italy Antithrombotic Agent Revenue, (US$, Mn), 2018-2029
Figure 24. Russia Antithrombotic Agent Revenue, (US$, Mn), 2018-2029
Figure 25. Nordic Countries Antithrombotic Agent Revenue, (US$, Mn), 2018-2029
Figure 26. Benelux Antithrombotic Agent Revenue, (US$, Mn), 2018-2029
Figure 27. By Region - Asia Antithrombotic Agent Revenue Market Share, 2018-2029
Figure 28. China Antithrombotic Agent Revenue, (US$, Mn), 2018-2029
Figure 29. Japan Antithrombotic Agent Revenue, (US$, Mn), 2018-2029
Figure 30. South Korea Antithrombotic Agent Revenue, (US$, Mn), 2018-2029
Figure 31. Southeast Asia Antithrombotic Agent Revenue, (US$, Mn), 2018-2029
Figure 32. India Antithrombotic Agent Revenue, (US$, Mn), 2018-2029
Figure 33. By Country - South America Antithrombotic Agent Revenue Market Share, 2018-2029
Figure 34. Brazil Antithrombotic Agent Revenue, (US$, Mn), 2018-2029
Figure 35. Argentina Antithrombotic Agent Revenue, (US$, Mn), 2018-2029
Figure 36. By Country - Middle East & Africa Antithrombotic Agent Revenue Market Share, 2018-2029
Figure 37. Turkey Antithrombotic Agent Revenue, (US$, Mn), 2018-2029
Figure 38. Israel Antithrombotic Agent Revenue, (US$, Mn), 2018-2029
Figure 39. Saudi Arabia Antithrombotic Agent Revenue, (US$, Mn), 2018-2029
Figure 40. UAE Antithrombotic Agent Revenue, (US$, Mn), 2018-2029
Figure 41. Pfizer Antithrombotic Agent Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 42. Bayer Antithrombotic Agent Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 43. Johnson & Johnson Antithrombotic Agent Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 44. Boehringer Ingelheim Pharmaceuticals Antithrombotic Agent Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 45. Daiichi Sankyo Antithrombotic Agent Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 46. Sanofi Antithrombotic Agent Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 47. GlaxoSmithKline Antithrombotic Agent Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 48. Bristol Myers Squibb Pharma Antithrombotic Agent Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 49. Pliva Antithrombotic Agent Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 50. Sandoz Antithrombotic Agent Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 51. Pharmacia Antithrombotic Agent Revenue Year Over Year Growth (US$, Mn) & (2018-2023)



★調査レポート[世界の抗血栓剤市場予測2023-2029:抗凝固薬、抗血小板薬] (コード:MMG23FB2160)販売に関する免責事項を必ずご確認ください。
★調査レポート[世界の抗血栓剤市場予測2023-2029:抗凝固薬、抗血小板薬]についてメールでお問い合わせ


◆H&Iグローバルリサーチのお客様(例)◆